[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global and United States Mitomycin C Market Research by Company, Type & Application 2013-2025

April 2018 | 75 pages | ID: G8EDE2036E2EN
HeyReport

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).

Market Segment as follows:

By Type
  • 2 Mg
  • 10 Mg
  • 40 Mg
  • Others
By Application
  • Cancer Treatment
  • Ophthalmic Use
  • Others
By Company
  • Kyowa-kirin
  • Intas Pharmaceuticals
  • Teva
  • Bristol-Myers Squibb
  • Aspen
  • Speciality European Pharma
  • Alkem Laboratories
  • Varifarma
  • APOGEPHA
The main contents of the report including:

Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
1 MARKET OVERVIEW

1.1 Market Segment Overview
  1.1.1 Product Definition
  1.1.2 Market by Type
    1.1.2.1 2 Mg
    1.1.2.2 10 Mg
    1.1.2.3 40 Mg
    1.1.2.4 Others
  1.1.3 Market by Application
    1.1.3.1 Cancer Treatment
    1.1.3.2 Ophthalmic Use
    1.1.3.3 Others
1.2 Global and Regional Market Size
  1.2.1 Global Overview
  1.2.2 United States Overview

2 GLOBAL AND REGIONAL MARKET BY COMPANY

2.1 Global
  2.1.1 Global Sales by Company
  2.1.2 Global Price by Company
2.2 United States
  2.2.1 United States Sales by Company
  2.2.2 United States Price by Company

3 GLOBAL AND REGIONAL MARKET BY TYPE

3.1 Global
  3.1.1 Global Sales by Type
  3.1.2 Global Price by Type
3.2 United States
  3.2.1 United States Sales by Type
  3.2.2 United States Price by Type

4 GLOBAL AND REGIONAL MARKET BY APPLICATION

4.1 Global
  4.1.1 Global Sales by Application
  4.1.2 Global Price by Application
4.2 United States
  4.2.1 United States Sales by Application
  4.2.2 United States Price by Application

5 REGIONAL TRADE

5.1 Export
5.2 Import

6 KEY MANUFACTURERS

6.1 Kyowa-kirin
  6.1.2 Company Information
  6.1.2 Product Specifications
  6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Intas Pharmaceuticals
  6.2.1 Company Information
  6.2.2 Product Specifications
  6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Teva
  6.3.1 Company Information
  6.3.2 Product Specifications
  6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 Bristol-Myers Squibb
  6.4.1 Company Information
  6.4.2 Product Specifications
  6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Aspen
  6.5.1 Company Information
  6.5.2 Product Specifications
  6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Speciality European Pharma
  6.6.1 Company Information
  6.6.2 Product Specifications
  6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Alkem Laboratories
  6.7.1 Company Information
  6.7.2 Product Specifications
  6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Varifarma
  6.8.1 Company Information
  6.8.2 Product Specifications
  6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 APOGEPHA
  6.9.1 Company Information
  6.9.2 Product Specifications
  6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

7 INDUSTRY UPSTREAM

7.1 Industry Chain
7.2 Raw Materials

8 MARKET ENVIRONMENT

8.1 SWOT
8.2 Porter's Five Forces

9 CONCLUSION

LIST OF TABLES

Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Kyowa-kirin
Table Sales Revenue, Volume, Price, Cost and Margin of Intas Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Teva
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Table Sales Revenue, Volume, Price, Cost and Margin of Aspen
Table Sales Revenue, Volume, Price, Cost and Margin of Speciality European Pharma
Table Sales Revenue, Volume, Price, Cost and Margin of Alkem Laboratories
Table Sales Revenue, Volume, Price, Cost and Margin of Varifarma
Table Sales Revenue, Volume, Price, Cost and Margin of APOGEPHA


LIST OF FIGURES

Figure 2 Mg Market Size and CAGR 2013-2017 (Million USD)
Figure 2 Mg Market Size and CAGR 2013-2017 (Volume)
Figure 2 Mg Market Forecast and CAGR 2018-2025 (Million USD)
Figure 2 Mg Market Forecast and CAGR 2018-2025 (Volume)
Figure 10 Mg Market Size and CAGR 2013-2017 (Million USD)
Figure 10 Mg Market Size and CAGR 2013-2017 (Volume)
Figure 10 Mg Market Forecast and CAGR 2018-2025 (Million USD)
Figure 10 Mg Market Forecast and CAGR 2018-2025 (Volume)
Figure 40 Mg Market Size and CAGR 2013-2017 (Million USD)
Figure 40 Mg Market Size and CAGR 2013-2017 (Volume)
Figure 40 Mg Market Forecast and CAGR 2018-2025 (Million USD)
Figure 40 Mg Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Cancer Treatment Market Size and CAGR 2013-2017 (Million USD)
Figure Cancer Treatment Market Size and CAGR 2013-2017 (Volume)
Figure Cancer Treatment Market Forecast and CAGR 2018-2025 (Million USD)
Figure Cancer Treatment Market Forecast and CAGR 2018-2025 (Volume)
Figure Ophthalmic Use Market Size and CAGR 2013-2017 (Million USD)
Figure Ophthalmic Use Market Size and CAGR 2013-2017 (Volume)
Figure Ophthalmic Use Market Forecast and CAGR 2018-2025 (Million USD)
Figure Ophthalmic Use Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Mitomycin C Market Size and CAGR 2013-2017 (Million USD)
Figure Global Mitomycin C Market Size and CAGR 2013-2017 (Volume)
Figure Global Mitomycin C Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Mitomycin C Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Mitomycin C Market Size and CAGR 2013-2017 (Million USD)
Figure United States Mitomycin C Market Size and CAGR 2013-2017 (Volume)
Figure United States Mitomycin C Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Mitomycin C Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Mitomycin C SWOT List
Figure Healthcare & Medical Porter's Five Forces


More Publications